top of page
XOFIGO: SPOT THE SPREAD
Background
Metastatic Castration-Resistant Prostate Cancer (mCRPC) patients are mostly focused on PSA #s, unaware of the likelihood their prostate cancer will spread to the bone, and what that may mean for their next treatment decision.
Goal: Create an educational campaign on the bone metastases of mCRPC to raise awareness of the symptoms, and that when patients spot the spread there’s more they can do to treat their cancer.
More brainstorm
bottom of page